leonarddurham315074

https://www.cooley.digital/references/ 

img src="" alt="List Of Danish Biotech Companies" align="right" style="max-width:32% max-height:242px; width:auto; margin:0px 10px; height:auto;"> <h1>A List Of Danish Biotech Companies</h1> <p>BoldData is an organization that offers accurate information about Danish biotech companies. This company's database includes information from Central Business Register and Danish Chambers of Commerce. Its precise information will help you build a successful marketing campaign for your biotech company. BoldData's information can help you to make your campaign more specific.

/p> <h2>Orphazyme

/h2>

p>Orphazyme, a biopharmaceutical firm in the final stages of development, is working on a novel treatment to the neurodegenerative disorder Niemann-Pick type C. The company plans to file an authorization to market request with the EMA in the second half of 2020.

/p> <p>The company has a history of focussing on rare diseases. It was created by Thomas Kirkegaard and Marja Jaattela in the year 2010. They've focused on the storage of lysosomes in particular.

/p> <h2>Symphogen

/h2>

p>French pharmaceutical Servier has reached an agreement that Symphogen will be acquired by Symphogen. French biotech company Symphogen. Symphogen is a Danish biotech company that has created an antibody discovery platform to aid in cancer treatment. Servier's pipeline of antibodies will be strengthened with this acquisition. Symphogen and Servier have been working together in the immuno-oncology space for over two years. The acquisition will allow Servier to fully benefit from Symphogen's technological capabilities and expertise.

/p> <p>Symphogen's management is experienced and diverse. Symphogen's CEO, Kirsten Drejer is an industry veteran with a record of building an impressive pipeline and moving Symphogen into a positive financial position. The company also has assets that have positive clinical data.

/p> <h2>Galecto Biotech

/h2>

p>Galecto Biotech, a Danish biotech company, is developing new medicines to treat serious diseases. The principal product it is developing inhibits a protein called galectin-3, which is involved in a myriad of inflammatory and immune processes. The company is currently conducting clinical trials to treat Idiopathic lung fibrosis. It has partnered with Bristol-Myers Squibb and has plans to start additional clinical trials for fibrotic illnesses.

/p> <p>Galecto Biotech's products are built on a research technology that targets the galectin-3 receptor. The team responsible for product development is dedicated to developing and commercializing chemically-derived therapeutic drugs. But they do not stop there. The company is also in advanced clinical trials using its galectin modulator. This could eventually lead to a cure of nasal polyposis and asthma.

/p> <h2>Novo Nordisk

/h2>

p>The biotech firm has also been successful at buying another biotech company in the U.S. in the last year, Dicerna Pharmaceuticals of Lexington. Dicerna has previously developed medicines made from RNA interference. This blocks certain genes that cause diseases.

/p> <p>The company plans to invest 17 billion Danish Kroner in three new manufacturing plants and expand an existing Kalundborg facility. These new facilities will increase the global value chain's capacity. They will also enhance the production of injectable and oral products. All new facilities will be fitted with state-of the-art production technology.

/p> <h2>Novozymes

/h2>

p>Novozymes is a Danish biotechnology company that specialises in industrial microorganisms and enzymes. The company has many end markets and its revenues are primarily generated in the following industries such as bio-energy, agriculture, and household care. Novozymes was established in 1988, and is headquartered in Copenhagen in Denmark.

/p> <p>The Danish biotech company has a lengthy track record of success in the roll-out of its products. Its predecessor, Nordisk Insulinlaboratorium, launched its first enzyme, trypsin, in 1941. This enzyme was initially utilized to soften leather. The company also invented the process of fermentation for enzyme production. It developed the first enzyme used in detergent production in the late 1980s: lipolase. This enzyme improved the freshness and quality of white breads and buns.

/p> <h2>Lilly

/h2>

p>Denmark is home to numerous leading biotech companies. These companies use innovative biotechnology to fight cancer, develop vaccines, and develop other medical solutions. Oncology Venture ApS specializes in research and development in the field of cancer. Other notable companies include AquaGreen, an Danish biotech engineering company, and STipe Therapeutics, which harnesses the immune system's natural defense mechanisms to fight cancer. Another Danish biotech company is Acesion Pharma, which is developing medicines to treat atrial flutter.

/p> <p>Denmark and Sweden have a long history in the biotechnology and medical technology industries. These two countries are among the five leading pharmaceutical exporters worldwide. Denmark also boasts one of the highest per-capita R&D expenditures in the European pharmaceutical industry, second only to Switzerland. In addition, 60 percent of Scandinavia's pharmaceutical industry is located in the Medicon Valley, a Danish-Swedish cross-border cluster.

/p> <h2>Innovent

/h2>

p>Innovent Biotech recently purchased exclusive rights for Eli Lilly's cancer drugs in China. Innovent will be in a position to control the pricing as well as marketing and distribution of these drugs. The companies plan to collaborate on the development of treatments for medical conditions that are unmet including cancer and eczema.

img width="345" src="">

/p> <p>Innovent has 16 potential products in its pipeline. Seven are currently under development for clinical trials. The company also has a partnership with Eli Lilly on co-development of three cancer treatments in China. Ascentage, an Danish biotech company, has collaborated with Oriza Ventures, and the Chinese state-owned SDIC Fund Management.

/p> <iframe height="282" allowfullscreen="true" frameborder="0" src="https://www.youtube.com/embed/ccGs550TSjk" width="505" style="margin:0px auto; display: block;"></iframe>